​

Funding Round

Series D - Quanta

Series D - Quanta

Investment Firm

Overview

Quanta develops an advanced haemodialysis systems for use in the home and clinic.

Announced Date

Jun 23, 2021

Funding Type

Series D

Highlights

Location

Europe

Social

Investor Lead

Novo Holdings

Novo Holdings

Novo Holdings is a debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and secondary_market and seed and venture firm.

Participant Investors

13

Investor Name
Participant InvestorNovo Holdings
Participant InvestorSeroba Life Sciences
Participant Investorb2venture
Participant InvestorWellington Partners
Participant InvestorBlackRock

Round Details and Background

Quanta raised $245000000 on 2021-06-23 in Series D

Quanta develops an advanced haemodialysis systems for use in the home and clinic.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 23, 2021
Series D - Quanta
14-245.0M
Aug 18, 2015
Grant - Quanta
1-2.9M
Nov 03, 2014
Series B - Quanta
7-43.1M
Nov 01, 2009
Series A - Quanta
4-14.3M

Recent Activity

There is no recent news or activity for this profile.